Paul MK - Search Results

1

Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer.

Shahbazi R, Kalishwaralal K, Paul MK, Anto RJ. Shahbazi R, et al. Among authors: paul mk. Front Bioeng Biotechnol. 2023 Sep 15;11:1288806. doi: 10.3389/fbioe.2023.1288806. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37786406 Free PMC article. No abstract available.

2

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches.

Singh M, Paul MK, Roy S. Singh M, et al. Among authors: paul mk. Front Oncol. 2023 Aug 23;13:1265523. doi: 10.3389/fonc.2023.1265523. eCollection 2023. Front Oncol. 2023. PMID: 37681032 Free PMC article. No abstract available.

3

Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis.

Ballav S, Bhosale M, Lokhande KB, Paul MK, Padhye S, Swamy KV, Ranjan A, Basu S. Ballav S, et al. Among authors: paul mk. Adv Biol (Weinh). 2023 Oct;7(10):e2300036. doi: 10.1002/adbi.202300036. Epub 2023 Apr 5. Adv Biol (Weinh). 2023. PMID: 37017501

4

Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.

Purbey PK, Roy K, Gupta S, Paul MK. Purbey PK, et al. Among authors: paul mk. Mol Immunol. 2023 Apr;156:111-126. doi: 10.1016/j.molimm.2023.03.009. Epub 2023 Mar 10. Mol Immunol. 2023. PMID: 36921486 Free PMC article. Review.

5

Organoid-based 3D in vitro microphysiological systems as alternatives to animal experimentation for preclinical and clinical research.

Mukhopadhyay C, Paul MK. Mukhopadhyay C, et al. Among authors: paul mk. Arch Toxicol. 2023 May;97(5):1429-1431. doi: 10.1007/s00204-023-03466-8. Epub 2023 Mar 14. Arch Toxicol. 2023. PMID: 36917352 No abstract available.

6

Lung cancer immunotherapy: progress, pitfalls, and promises.

Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK. Lahiri A, et al. Among authors: paul mk. Mol Cancer. 2023 Feb 21;22(1):40. doi: 10.1186/s12943-023-01740-y. Mol Cancer. 2023. PMID: 36810079 Free PMC article. Review.

7

The actin cytoskeleton: Morphological changes in pre- and fully developed lung cancer.

Basu A, Paul MK, Weiss S. Basu A, et al. Among authors: paul mk. Biophys Rev (Melville). 2022 Dec 30;3(4):041304. doi: 10.1063/5.0096188. eCollection 2022 Dec. Biophys Rev (Melville). 2022. PMID: 38505516 Free PMC article. Review.

8

Angiogenic stimulation strategies in bone tissue regeneration.

Mahapatra C, Kumar P, Paul MK, Kumar A. Mahapatra C, et al. Among authors: paul mk. Tissue Cell. 2022 Dec;79:101908. doi: 10.1016/j.tice.2022.101908. Epub 2022 Aug 27. Tissue Cell. 2022. PMID: 36084409 Review.

9

Modulating Polymerization Thermodynamics of Thiolactones Through Substituent and Heteroatom Incorporation.

Stellmach KA, Paul MK, Xu M, Su YL, Fu L, Toland AR, Tran H, Chen L, Ramprasad R, Gutekunst WR. Stellmach KA, et al. Among authors: paul mk. ACS Macro Lett. 2022 Jul 19;11(7):895-901. doi: 10.1021/acsmacrolett.2c00319. Epub 2022 Jul 5. ACS Macro Lett. 2022. PMID: 35786872

10

Drug repurposing-an emerging strategy in cancer therapeutics.

Turabi KS, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J. Turabi KS, et al. Among authors: paul mk. Naunyn Schmiedebergs Arch Pharmacol. 2022 Oct;395(10):1139-1158. doi: 10.1007/s00210-022-02263-x. Epub 2022 Jun 13. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35695911 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page